The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 12, 2022
Filed:
Mar. 19, 2019
Applicant:
Boehringer Ingelheim Vetmedica Gmbh, Ingelheim am Rhein, DE;
Inventors:
Ramesh Koukuntla, Ames, IA (US);
Jana M. Larsen, Story City, IA (US);
Robert Barry Mandell, Collins, IA (US);
Luka N. Pelz, Ankeny, IA (US);
Eric Martin Vaughn, Ames, IA (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); A61K 39/145 (2006.01); A61K 48/00 (2006.01); C12N 7/00 (2006.01); A61P 31/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 39/145 (2013.01); A61K 48/00 (2013.01); A61P 31/00 (2018.01); C12N 7/00 (2013.01); C12N 2710/16021 (2013.01); C12N 2710/16043 (2013.01); C12N 2710/16052 (2013.01); C12N 2710/16062 (2013.01); C12N 2710/16734 (2013.01); C12N 2710/16743 (2013.01); C12N 2710/16762 (2013.01); C12N 2760/16034 (2013.01); C12N 2760/16071 (2013.01);
Abstract
The present invention relates to the field of (vector) vaccines, and especially to novel EHV's having an inactivation of UL18 and/or UL8. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.